Mereo BioPharma Group Plc (MREO)
0.2686
-0.01
(-2.93%)
USD |
NASDAQ |
Sep 02, 16:00
0.2686
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Research and Development Expense (Annual) : 17.81M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 17.81M |
| December 31, 2024 | 20.94M |
| December 31, 2023 | 17.49M |
| December 31, 2022 | 30.75M |
| December 31, 2021 | 32.40M |
| December 31, 2020 | 20.96M |
| Date | Value |
|---|---|
| December 31, 2019 | 30.12M |
| December 31, 2018 | 30.27M |
| December 31, 2017 | 44.57M |
| December 31, 2016 | 33.14M |
| December 31, 2015 | 8.319M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.026M |
| NuCana Plc | 16.79M |
| BioNTech SE | 2.376B |
| Silence Therapeutics Plc | 60.29M |
| Autolus Therapeutics Plc | 128.59M |